Saman Daroo 8 launching Safacto in biotech meds sector

Saman Daroo 8 launching Safacto in biotech meds sector

Saman Daroo 8 has operationalized the production line of biotech-based meds for Factor VIII deficiency, a rare bleeding disorder.

The production line of recombinant Factor VIII, also known as anti-hemophilic factor or AHF, became operational at Saman Daroo 8 Pharmaceutical Company in the presence of the general custodian of the Holy Shrine of Imam Reza (AS) in the holy city of Mashhad.

Brand-named Safacto, the biotechnology-derived medicine is produced in a building as large as 4,200 square meters in three stories, meeting the latest requirements of global standards.

Located at Khorasan Razavi Science and Technology Park, the site is employed to produce other types of biotechnology-derived medicines for domestic, regional and trans-regional markets.

As the largest accelerator in eastern Iran, Saman Daroo 8 Pharmaceutical Company is currently conducting several research and study projects on Monoclonal antibodies (mAb or moAb), to produce oncology (cancerous tumors) drugs.

According to the managing director of the company, Saman Daroo 8 has made Iran the fourth country in the world with the technology to produce recombinant Factor VIII.

“The technical know-how of Factor VIII was previously at the disposal of three American-European corporations. Saran Daroo 8 could localize this technology and this is an honor for Astan Quds Razavi,” Maid Tabasi told reporters in a presser.“Factor VIII is currently produced in the world either from donated blood plasma, or alternatively through recombinant process. Saman Daroo produces Factor VIII through biotech and recombinant method. This product is of better quality and more purity in comparison with plasma-based medicine. That is why the hemophiliac patients prefer to use this type of medicine.”

Tabasi further noted that Saman Daroo will first meet all the domestic demands to this product and then will follow the company’s export policies. “During the recent years, the company had customers from the neighboring countries, but regional markets will be covered once production capacity is boosted and the entire domestic demands are met.” 

Astan Quds Razavi (AQR) is the body in charge of the Holy Shrine of Imam Reza (AS).

Be the first to comment

نظر شما